Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP863482.RAHGJJI9uNybphS_hY1M3Wx1620oP8BKhY9l91XA9PHiM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP863482.RAHGJJI9uNybphS_hY1M3Wx1620oP8BKhY9l91XA9PHiM130_assertion type Assertion NP863482.RAHGJJI9uNybphS_hY1M3Wx1620oP8BKhY9l91XA9PHiM130_head.
- NP863482.RAHGJJI9uNybphS_hY1M3Wx1620oP8BKhY9l91XA9PHiM130_assertion description "[Immunohistochemical analysis detected robust and frequent expression of C35 protein, including 32% of grade 1 and 66% of grades 2 and 3 infiltrating ductal carcinomas of the breast (in contrast to 20% overexpressing HER-2/neu), 38% of infiltrating lobular carcinoma (typically HER-2/neu negative), as well as tumors arising in other tissues.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP863482.RAHGJJI9uNybphS_hY1M3Wx1620oP8BKhY9l91XA9PHiM130_provenance.
- NP863482.RAHGJJI9uNybphS_hY1M3Wx1620oP8BKhY9l91XA9PHiM130_assertion evidence source_evidence_literature NP863482.RAHGJJI9uNybphS_hY1M3Wx1620oP8BKhY9l91XA9PHiM130_provenance.
- NP863482.RAHGJJI9uNybphS_hY1M3Wx1620oP8BKhY9l91XA9PHiM130_assertion SIO_000772 17121940 NP863482.RAHGJJI9uNybphS_hY1M3Wx1620oP8BKhY9l91XA9PHiM130_provenance.
- NP863482.RAHGJJI9uNybphS_hY1M3Wx1620oP8BKhY9l91XA9PHiM130_assertion wasDerivedFrom befree-20140225 NP863482.RAHGJJI9uNybphS_hY1M3Wx1620oP8BKhY9l91XA9PHiM130_provenance.
- NP863482.RAHGJJI9uNybphS_hY1M3Wx1620oP8BKhY9l91XA9PHiM130_assertion wasGeneratedBy ECO_0000203 NP863482.RAHGJJI9uNybphS_hY1M3Wx1620oP8BKhY9l91XA9PHiM130_provenance.